Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$22.18 -3.25 (-12.78%)
At close: Sep 24, 2026 · 4:00 PM EDT

Acadia Pharmaceuticals (ACAD) Capital Expenditures Growth (1y) (2013 - 2026)

Analysis

Acadia Pharmaceuticals (ACAD) Capital Expenditures Growth (1y) (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (1y) (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 26.65%
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 19.70%
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn 16.88%
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn 3.02%
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn -15.78%
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 39.02%
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn 30.84%
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn -13.75%
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn -22.99%
10 Acadia Pharmaceuticals 4.38 Bn 3.42 Bn 279.64 Mn 1,613.47%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1,613.47%
Dec 31, 2025 784.11%
Sep 30, 2025 454.29%
Dec 31, 2021 -99.95%
Jun 30, 2021 -98.47%
Mar 31, 2021 15.20%
Dec 31, 2020 865.70%
Sep 30, 2020 2,051.25%
Jun 30, 2020 14,565.00%
Mar 31, 2020 13.63%
Dec 31, 2019 -60.65%
Sep 30, 2019 -92.12%
Jun 30, 2019 -82.61%
Mar 31, 2019 83.48%
Dec 31, 2018 7,414.29%
Sep 30, 2018 1,712.50%
Jun 30, 2018 -56.44%
Mar 31, 2018 -7.63%
Dec 31, 2017 -97.19%
Sep 30, 2017 -88.09%
API Access

Acadia Pharmaceuticals Capital Expenditures Growth (1y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures-growth-1y&ticker=ACAD&period=max&api_key=YOUR_API_KEY